All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0622-ZP3328 | Anti-NKG2DL h(VHH1-VHH2-CD28-CD3ζ) Biepitopic CAR, pCDCAR1 | Human | VHH1-VHH2-CD28-CD3ζ | Lentiviral vector | T Cell | ||||
XS-0622-ZP3500 | Anti-NKG2DL h(VHH1-VHH2-4-1BB-CD3ζ) Biepitopic CAR, pCDCAR1 | VHH1-VHH2-4-1BB-CD3ζ | Lentiviral vector | T Cell | |||||
XS-0722-YF53 | TS-Fluc Anti-Human NKG2DL scFv (NKG2D receptor) CD28-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF113 | TS-Fluc Anti-Human NKG2DL scFv (NKG2D receptor) 4-1BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF173 | TS-Fluc Anti-Human NKG2DL scFv (NKG2D receptor) CD28-4-1BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF233 | TS-IL15 SA Anti-Human NKG2DL scFv (NKG2D receptor) CD28-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF293 | TS-IL15 SA Anti-Human NKG2DL scFv (NKG2D receptor) 4-1BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF353 | TS-IL15 SA Anti-Human NKG2DL scFv (NKG2D receptor) CD28-4-1BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0822-YF593 | Anti-Human NKG2DL (XW-593) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-593 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF594 | Anti-Human NKG2DL (XW-594) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-594 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF733 | Anti-Human NKG2DL (NKG2D receptor) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1653 | Anti-Human NKG2DL (NKG2D receptor) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2573 | Anti-Human NKG2DL (NKG2D receptor) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-1122-YF733 | Anti-NKG2DL KIR CAR (scFv-KIR2DS2-DAP12, NKG2D receptor), pCDCAR1 | Human | NKG2D receptor | Human | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF1513 | Anti-NKG2DL TCR-ABR (scFv-TCRα, XW-593) CAR Plasmid, pCDCAR1 | Human | XW-593 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1514 | Anti-NKG2DL TCR-ABR (scFv-TCRα, XW-594) CAR Plasmid, pCDCAR1 | Human | XW-594 | Human | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1653 | Anti-NKG2DL TCR-ABR (scFv-TCRα, NKG2D receptor) CAR Plasmid, pCDCAR1 | Human | NKG2D receptor | Human | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF2433 | Anti-NKG2DL TCR-ABR (scFv-TCRβ, XW-593) CAR Plasmid, pCDCAR1 | Human | XW-593 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2434 | Anti-NKG2DL TCR-ABR (scFv-TCRβ, XW-594) CAR Plasmid, pCDCAR1 | Human | XW-594 | Human | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2573 | Anti-NKG2DL TCR-ABR (scFv-TCRβ, NKG2D receptor) CAR Plasmid, pCDCAR1 | Human | NKG2D receptor | Human | scFv-TCRβ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION